ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis

Tuesday, April 1, 2014

Submitted by

Mark Ferguson

Source

Source Name: New England Journal of Medicine

Source URL: http://www.nejm.org/doi/full/10.1056/NEJMoa1400590?query=OF&

Author(s)

DH Adams and others for the US CoreValve Clinical Investigators

Transcatheter AVR (TAVR) was compared to surgical AVR for treatment of aortic stenosis in 795 high risk patients. TAVR was associated with a decreased risk of death at 1 year (14% vs 19%; p<0.04). This was likely due to a reduction in the risk of adverse cardiovascular and cerebrovascular events.